loadpatents
name:-0.029467821121216
name:-0.013031005859375
name:-0.0052149295806885
Spreter Von Kreudenstein; Thomas Patent Filings

Spreter Von Kreudenstein; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Spreter Von Kreudenstein; Thomas.The latest application filed is for "modified antigen binding polypeptide constructs and uses thereof".

Company Profile
4.11.24
  • Spreter Von Kreudenstein; Thomas - Vancouver CA
  • SPRETER VON KREUDENSTEIN; Thomas - Wiesbaden DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modified Antigen Binding Polypeptide Constructs And Uses Thereof
App 20220251242 - SANCHES; Mario ;   et al.
2022-08-11
Engineered Immunoglobulin Heavy Chain-light Chain Pairs And Uses Thereof
App 20220227840 - CORPER; Adam Louis ;   et al.
2022-07-21
Modified antigen binding polypeptide constructs and uses thereof
Grant 11,306,156 - Sanches , et al. April 19, 2
2022-04-19
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant 11,286,293 - Corper , et al. March 29, 2
2022-03-29
Drug-conjugated bi-specific antigen-binding constructs
Grant 11,147,886 - Ng , et al. October 19, 2
2021-10-19
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
App 20210317212 - Ng; Gordon Yiu Kon ;   et al.
2021-10-14
Engineered Immunoglobulin Heavy Chain-Light Chain Pairs and Uses Thereof
App 20210309760 - Corper; Adam Louis ;   et al.
2021-10-07
Compositions Including Cd3 Antigen Binding Fragments And Uses Thereof
App 20210277118 - SPRETER VON KREUDENSTEIN; Thomas
2021-09-09
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant 11,078,296 - Corper , et al. August 3, 2
2021-08-03
STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN
App 20200087414 - Spreter Von Kreudenstein; Thomas ;   et al.
2020-03-19
Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
Grant 10,508,154 - Dixit , et al. Dec
2019-12-17
Stable heterodimeric antibody design with mutations in the Fc domain
Grant 10,457,742 - Spreter Von Kreudenstein , et al. Oc
2019-10-29
Engineered Immunoglobulin Heavy Chain-light Chain Pairs And Uses Thereof
App 20190085055 - CORPER; Adam Louis ;   et al.
2019-03-21
Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
Grant 10,077,298 - Corper , et al. September 18, 2
2018-09-18
Drug-conjugated Bi-specific Antigen-binding Constructs
App 20180193477 - Ng; Gordon Yiu Kon ;   et al.
2018-07-12
Engineered Immunoglobulin Heavy Chain-light Chain Pairs And Uses Thereof
App 20180179296 - CORPER; Adam Louis ;   et al.
2018-06-28
Crystal structures of heterodimeric Fc domains
Grant 9,988,460 - Spreter Von Kreudenstein , et al. June 5, 2
2018-06-05
CRYSTAL STRUCTURES OF HETERODIMERIC Fc DOMAINS
App 20180030150 - SPRETER VON KREUDENSTEIN; Thomas ;   et al.
2018-02-01
STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN
App 20180016347 - Spreter Von Kreudenstein; Thomas ;   et al.
2018-01-18
Crystal structures of heterodimeric Fc domains
Grant 9,732,155 - Spreter Von Kreudenstein , et al. August 15, 2
2017-08-15
Modified Antigen Binding Polypeptide Constructs And Uses Thereof
App 20170204199 - Sanches; Mario ;   et al.
2017-07-20
Single-Arm Monovalent Antibody Constructs and Uses Thereof
App 20170174783 - NG; Gordon Yiu Kon ;   et al.
2017-06-22
Process And Methods For Efficient Manufacturing Of Highly Pure Asymmetric Antibodies In Mammalian Cells
App 20170158779 - Dixit; Surgit Bhimarao ;   et al.
2017-06-08
Stable heterodimeric antibody design with mutations in the Fc domain
Grant 9,574,010 - Spreter Von Kreudenstein , et al. February 21, 2
2017-02-21
Bispecific CD3 and CD19 Antigen Binding Constructs
App 20160355588 - Ng; Gordon Yiu Kon ;   et al.
2016-12-08
Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
Grant 9,499,634 - Dixit , et al. November 22, 2
2016-11-22
Bi-specific Cd3 And Cd19 Antigen-binding Constructs
App 20160326249 - Ng; Gordon Yiu Kon ;   et al.
2016-11-10
Engineered Immunoglobulin Heavy Chain-light Chain Pairs And Uses Thereof
App 20150307594 - Corper; Adam Louis ;   et al.
2015-10-29
CRYSTAL STRUCTURES OF HETERODIMERIC Fc DOMAINS
App 20150284470 - Spreter Von Kreudenstein; Thomas ;   et al.
2015-10-08
Single-Arm Monovalent Antibody Constructs and Uses Thereof
App 20150125449 - Ng; Gordon Yiu Kon ;   et al.
2015-05-07
Engineered Immunoglobulin Heavy Chain-Light Chain Pairs And Uses Thereof
App 20140200331 - Corper; Adam Louis ;   et al.
2014-07-17
Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs
App 20140154253 - NG; Gordon Yiu Kon ;   et al.
2014-06-05
Process and Methods for Efficient Manufacturing of Highly Pure Asymmetric Antibodies in Mammalian Cells
App 20140051835 - DIXIT; Surjit Bhimarao ;   et al.
2014-02-20
Heteromultimer Constructs of Immunoglobulin Heavy Chains with Mutations in the Fc Domain
App 20130336973 - SPRETER VON KREUDENSTEIN; Thomas ;   et al.
2013-12-19
Stable Heterodimeric Antibody Design with Mutations in the Fc Domain
App 20130195849 - SPRETER VON KREUDENSTEIN; Thomas ;   et al.
2013-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed